Education
About Us
Working with TipRanks
Follow Us
Andrew Sinclair Insider Profile
11 Followers
Andrew Sinclair, Director at Soleno Therapeutics, holds 17.70K shares in Adicet Bio (Ticker: ACET), holds 10.49K shares in Soleno Therapeutics (Ticker: SLNO), holds 0.00 shares in Sierra Oncology (Ticker: SRRA).
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+11.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Sinclair holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 27, 2018 - Dec 27, 2019
Return:+64.40%
The most profitable trade made by Andrew Sinclair
Andrew Sinclair's Trading History
Soleno Therapeutics
Jun 09, 2025
Director
Uninformative Buy
―
$674.26K
Sierra Oncology
Jul 01, 2022
―
Uninformative Sell
72.28M
$0.00
Adicet Bio
Jun 13, 2025
Director
Uninformative Buy
―
$17.33K
Verona Pharma
―
―
―
―
List of latest transactions for each holding click on a transaction to see Andrew Sinclair's performance on stock
You May Also Like
Andrew Sinclair insider profile FAQ
What is the percentage of profitable transactions made by Andrew Sinclair?
The percentage of profitable transactions made by Andrew Sinclair is 75%.
What is the average return per transaction made by Andrew Sinclair?
The average return per transaction made by Andrew Sinclair is 11.10%.
What stocks does Andrew Sinclair hold?
Andrew Sinclair holds: SLNO, SRRA, ACET, VRNA stocks.
What was Andrew Sinclair’s latest transaction?
Andrew Sinclair latest transaction was an Uninformative Buy of ―.
What was Andrew Sinclair's most profitable transaction?
Andrew Sinclair’s most profitable transaction was an Informative Buy of SLNO stock on December 27, 2018. The return on the trade was 64.40%.
What is Andrew Sinclair's role in Soleno Therapeutics?
Andrew Sinclair's role in Soleno Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.